Home

Mittie Doyle

CIK 1918845 · Chief Medical Officer · last filed 2026-07-02

Mittie Doyle is a Chief Medical Officer who has filed 21 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for AVTX, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$2.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.10M

Companies

3

Total Filings

21

Lifetime Open-Market Net

-$2.91M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Chief Medical Officer 56,430 $19.52 $1.10M -$2.91M 14 2026-07-02
CGEM Director — $17.47 — $0 2 2026-06-18
DICE Therapeutics, Inc. (DICE) Delisted Director — $47.55 — $0 2 2023-08-09

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 AVTX Mixed — -$42.4K EDGAR
2026-06-25 AVTX Mixed — -$14.4K EDGAR
2026-06-18 CGEM Grant (A) — $0 EDGAR
2026-06-12 AVTX Tax (F) −1,084 -$14.2K EDGAR
2026-06-01 AVTX Mixed — -$5.4K EDGAR
2026-05-26 AVTX Grant (A) +43,500 $0 EDGAR
2026-05-19 AVTX Mixed — -$18.3K EDGAR
2026-05-07 AVTX Mixed — -$996.4K EDGAR
2026-05-06 AVTX Notice (144) −54,508 -$886.3K EDGAR
2026-04-08 AVTX Mixed — -$21.3K EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.